Pharmaceutical Executive
Limitations of the Drug Supply Chain Security Act for pharma-and three strategies to fix them.
Peter M.O. Wong
Advertisement
Articles by Peter M.O. Wong
Advertisement
Latest Updated Articles
Closing the Gaps in Drug Chain of CustodyApril 28th 2016
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
5